Session
EXPERTS
Co-Creating the Future: Envisioning the World Ahead
Based on the latest data, key societal challenges will be analyzed, focusing on what is needed to realize a sustainable society. The importance of open innovation in building an environment that fosters sustainable value creation will also be discussed
Available passes
- Executive
- Business/Startup
- Rising Star
- City
Language：Japanese
Speakers
-
Kensuke Nishiji
Bank of Tokyo-Mitsubishi UFJ, Ltd.
Kensuke Nishiji
Deputy General Manager, Business Co-Creation Investment Division, Mitsubishi UFJ Bank, Ltd.
Joined the Bank of Tokyo-Mitsubishi in 1999. After the long career in project finance, has engaged in various projects related to the transformation of bank’s business, including establishment of an infrastructure investment company and launch of ESG-related businesses. At present, engaged in equity investment in fields such as space, semiconductors, and GX. Serves as a director for two startups (SDS and DMP Axyz). As the leader of cross-division open innovation team in the bank, leading a number of innitiatives, including the creation of a startup ecosystem at Takanawa Gateway City.
-
Fumiaki Ikeno
Stanford University / Medical Officer of MedVenture Partners
Fumiaki Ikeno
Stanford University Principal Investigator/Physician, Director and Chief Medical Officer of MedVenture Partners
A graduate of Jichi Medical University, he began his research career at the Department of Cardiology,Stanford University, in 2001, where he was involved in research and development, animal testing,and clinical trials for a U.S. medical device venture. He has extensive advisory experience in themedical device field and is familiar with the medical situation in Japan and the United States. He hasalso participated in projects involving Japanese and U.S. regulatory authorities in medical devices andis working to establish a cross-border medical device ecosystem.In addition to his research, he has been teaching at Stanford University since 2002 as a member of the Stanford Biodesign Advisory Faculty, where he is training entrepreneurs in the medical devicefield. He is also deeply involved in the establishment of the Japanese version of Biodesign.In addition,he is actively working to establish a Silicon Valley-style medical device ecosystem in Japan.
-
Mari Ogiso
SDG Impact Japan Co., Ltd.
Mari Ogiso
SDG Impact Japan Co., Ltd. Representative Director and Co-CEO
Engaged extensively in businesses aimed at achieving the SDGs, particularly SDG finance, including impact investment, support for social entrepreneurs, and the promotion of inclusive business. In 2017, established Asia's first gender investment fund, the Asia Women Impact Fund. Has held positions such as Head of Capital Markets at the World Bank, Tokyo Representative for the Multilateral Investment Guarantee Agency (MIGA) of the World Bank Group, Representative of Dalberg Japan, Diversity Director and Secretary-General of the Human Rights Committee at Fast Retailing Group. Serves as a W20 Japan Delegate, an expert committee member for JICA's Overseas Investment and Loan Committee, and an advisor for WE Empower. Graduated from the University of Tokyo with a degree in Economics and holds a master's degree from the Fletcher School at Tufts
